Interim Access to the International Space Station Using Evolved Expendable Launch Vehicles

2010 ◽  
Vol 47 (3) ◽  
pp. 503-520 ◽  
Author(s):  
Stephen A. Whitmore ◽  
Tyson K. Smith
Author(s):  
Vladimir A. SOLOVIEV ◽  
RESHETNIKOV Mikhail N. RESHETNIKOV Mikhail N ◽  
Viktor V. SINYAVSKIY ◽  
Sergey Yu. SHACHNEV

The article briefly discusses the key achievements of the enterprise over 75 years from the formation of OKB-1 headed by S.P. Korolev for producing intercontinental range missiles to the current status of RSC Energia being the country’s and world leader in manned space flight. The developed intercontinental missiles R-7 and a closed-loop oxygen-hydrocarbon liquid-propellant rocket engine provided the basis for developing integrated launch vehicles which were used to launch the world's first Earth satellite, the first cosmonaut on the Earth, automatic interplanetary stations to the Moon, Venus, Mars. The diversification of the enterprise impeded S.P. Korolev to concentrate on manned space flights, and he initiated the transfer of development and manufacture of combat missiles to Makeyev DB, integrated launch vehicles to TsSKB Progress, communication and other satellites to M.F. Reshetnev ISS, lunar and interplanetary stations to S.A.Lavochkin NPO. In the 1980s under the guidance of V.P. Glushko the Energia super-heavy launch vehicle and Energia-Buran system in unmanned configuration were developed and successfully launched on the first try. The Salyut manned single-module orbital stations, Mir multifunctional multi-module space laboratory and successfully operating upgraded manned transportation (Soyuz) and logistics (Progress) spacecraft were developed. In the hard times of 1990s, RSC Energia under the guidance of Yu.P. Semenov saved the national cosmonautics through commercial research performed on the Mir station. At present, by launching three additional modules RSC Energia is completing assembly and integration of the Russian Segment into the International Space Station. Keywords. ОKB-1, S.P.Korolev RSC Energia, V.P. Glushko, Yu.S. Semenov, integrated launch vehicle, orbital station, crew transportation spacecraft, logistics transportation spacecraft, International Space Station.


2005 ◽  
Author(s):  
Danielle Paige Smith ◽  
Vicky E. Byrne ◽  
Cynthia Hudy ◽  
Mihriban Whitmore

2020 ◽  
Vol 91 (1) ◽  
pp. 41-45 ◽  
Author(s):  
Virginia. E. Wotring ◽  
LaRona K. Smith

INTRODUCTION: There are knowledge gaps in spaceflight pharmacology with insufficient in-flight data to inform future planning. This effort directly addressed in-mission medication use and also informed open questions regarding spaceflight-associated changes in pharmacokinetics (PK) and/or pharmacodynamics (PD).METHODS: An iOS application was designed to collect medication use information relevant for research from volunteer astronaut crewmembers: medication name, dose, dosing frequency, indication, perceived efficacy, and side effects. Leveraging the limited medication choices aboard allowed a streamlined questionnaire. There were 24 subjects approved for participation.RESULTS: Six crewmembers completed flight data collection and five completed ground data collection before NASA’s early study discontinuation. There were 5766 medication use entries, averaging 20.6 ± 8.4 entries per subject per flight week. Types of medications and their indications were similar to previous reports, with sleep disturbances and muscle/joint pain as primary drivers. Two subjects treated prolonged skin problems. Subjects also used the application in unanticipated ways: to note drug tolerance testing or medication holiday per research protocols, and to share data with flight surgeons. Subjects also provided usability feedback on application design and implementation.DISCUSSION: The volume of data collected (20.6 ± 8.4 entries per subject per flight week) is much greater than was collected previously (<12 per person per entire mission), despite user criticisms regarding app usability. It seems likely that improvements in a software-based questionnaire application could result in a robust data collection tool that astronauts find more acceptable, while simultaneously providing researchers and clinicians with useful data.Wotring VE, Smith LK. Dose tracker application for collecting medication use data from International Space Station crew. Aerosp Med Hum Perform. 2020; 91(1):41–45.


2004 ◽  
Vol 10 (2-3) ◽  
pp. 81-86 ◽  
Author(s):  
S.I. Klimov ◽  
◽  
V.Ye. Korepanov ◽  

Sign in / Sign up

Export Citation Format

Share Document